81 related articles for article (PubMed ID: 33455094)
21. Identification of common genetic features and pathways involved in pulmonary lymphangioleiomyomatosis and ER-positive breast cancer.
Yang L; Xiao Y; Ren S
Medicine (Baltimore); 2023 Sep; 102(39):e34810. PubMed ID: 37773865
[TBL] [Abstract][Full Text] [Related]
22. Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
Su Q; Dai B; Zhang H; Zhang S
Comput Math Methods Med; 2022; 2022():8430485. PubMed ID: 35799671
[TBL] [Abstract][Full Text] [Related]
23. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
[TBL] [Abstract][Full Text] [Related]
24. Identification of genes and pathways associated with menopausal status in breast cancer patients using two algorithms.
Cheng M; Wang L; Xuan Y; Zhai Z
BMC Womens Health; 2024 Jan; 24(1):4. PubMed ID: 38166892
[TBL] [Abstract][Full Text] [Related]
25. Hub genes identification and association of key pathways with hypoxia in cancer cells: A bioinformatics analysis.
Aziz F; Shoaib N; Rehman A
Saudi J Biol Sci; 2023 Sep; 30(9):103752. PubMed ID: 37593462
[TBL] [Abstract][Full Text] [Related]
26. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
27. Identification and analysis of the molecular targets of statins in colorectal cancer.
Firouzjaei AA; Mahmoudi A; Almahmeed W; Teng Y; Kesharwani P; Sahebkar A
Pathol Res Pract; 2024 Apr; 256():155258. PubMed ID: 38522123
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Differentially Expressed Genes and Molecular Pathways in Familial Hypercholesterolemia Involved in Atherosclerosis: A Systematic and Bioinformatics Approach.
Udhaya Kumar S; Thirumal Kumar D; Bithia R; Sankar S; Magesh R; Sidenna M; George Priya Doss C; Zayed H
Front Genet; 2020; 11():734. PubMed ID: 32760426
[No Abstract] [Full Text] [Related]
29. Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells.
Behera A; Ashraf R; Srivastava AK; Kumar S
Heliyon; 2020 Sep; 6(9):e04820. PubMed ID: 32984578
[TBL] [Abstract][Full Text] [Related]
30. Identification of Key Genes and Pathways Associated with
Zhou Y; Zhang C; Zhou Z; Zhang C; Wang J
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563641
[TBL] [Abstract][Full Text] [Related]
31. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talked with primary pancreatic stellate cells using bioinformatics analysis.
Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
Neoplasma; 2019 Jun; ():. PubMed ID: 31167532
[TBL] [Abstract][Full Text] [Related]
32. Tracing the pathways and mechanisms involved in the anti-breast cancer activity of glycyrrhizin using bioinformatics tools and computational methods.
Poustforoosh A; Faramarz S; Negahdaripour M; Tüzün B; Hashemipour H
J Biomol Struct Dyn; 2024; 42(2):819-833. PubMed ID: 37042955
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis to identify breast cancer-related potential targets and candidate small molecule drugs.
Hong H; Chen H; Zhao J; Qin L; Li H; Huo H; Shi S
Mutat Res; 2023; 827():111830. PubMed ID: 37437506
[TBL] [Abstract][Full Text] [Related]
34. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
Zhao W; Chang Y; Wu Z; Jiang X; Li Y; Xie R; Fu D; Sun C; Gao J
PeerJ; 2023; 11():e15703. PubMed ID: 37483962
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognosis analysis of GINS subunits in human breast cancer.
Li H; Cao Y; Ma J; Luo L; Ma B
Medicine (Baltimore); 2021 Mar; 100(11):e24827. PubMed ID: 33725952
[TBL] [Abstract][Full Text] [Related]
36. Identification of key genes and molecular mechanisms of chronic urticaria based on bioinformatics.
Guo H; Guo L; Li L; Li N; Lin X; Wang Y
Skin Res Technol; 2024 Apr; 30(4):e13624. PubMed ID: 38558219
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive bioinformation analysis of differentially expressed genes in recurrent pregnancy loss.
Wang H; Liu Z; Meng L; Zhang X
Hum Fertil (Camb); 2023 Dec; 26(5):1015-1022. PubMed ID: 35306956
[TBL] [Abstract][Full Text] [Related]
38. The identification of key genes and pathways in glioblastoma by bioinformatics analysis.
Farsi Z; Allahyari Fard N
Mol Cell Oncol; 2023; 10(1):2246657. PubMed ID: 37593751
[TBL] [Abstract][Full Text] [Related]
39. Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities.
Nayan SI; Rahman MH; Hasan MM; Raj SMRH; Almoyad MAA; Liò P; Moni MA
Life Sci; 2023 Dec; 335():122244. PubMed ID: 37949208
[TBL] [Abstract][Full Text] [Related]
40. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
